z-logo
Premium
Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas
Author(s) -
Rao Vishal U. S.,
Subash Anand,
Bhargavi Vidya,
Sinha Piyush,
Bagadia Ritvi K.,
Kudpaje Akshay,
Arakeri Gururaj,
Subbanna Indusekhara
Publication year - 2021
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26585
Subject(s) - medicine , embolization , surgery , perioperative , transoral robotic surgery , tongue , vascularity , swallowing , pathology
Abstract Background The incidence of oropharyngeal carcinoma has been on the rise in recent decades. About 30% of patients who undergo definitive chemoradiation as the initial treatment present with residual/recurrent disease. In such a situation, surgical salvage either in the form of traditional open surgery or transoral robotic surgery (TORS) remains a viable treatment option. However, the extensive vascular supply of the posterior tongue and tonsillar bed increases the risk of perioperative bleeding, which is a key concern. The article describes the technique of selective pre‐operative embolization to reduce the risk of perioperative bleeding and enumerate its advantages in providing a bloodless field during surgery. Methods Prospective study of 5 patients with recurrent or residual midline BOT tumours who underwent TORS after selective lingual artery embolization at our centre. Results and Conclusions None of the patients had any major perioperative bleeding or post procedural complications. All the patients after TORS had their tongue vascularity preserved with adequate recovery of tongue functions. Selective embolization of the feeder vessels provides a favorable bloodless surgical field without affecting the vascular integrity of the remnant tongue. This added advantage helps restoring the normal oral phase of swallowing.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here